VTRSViatris Inc.

$16B

FY 2009 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5.1B-0.9% YoY

Gross Profit

$2.1B40.7% margin

Operating Income

$523M10.3% margin

Net Income

$233M4.6% margin

EPS (Diluted)

$0.30

Cash Flow

Operating Cash Flow

$605M

Free Cash Flow

$451M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$7.7B

Stockholders' Equity

$3.1B

Cash & Equivalents

$428M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.1B	$5.1B	-0.9%
Gross Profit	$2.1B	$2.1B	+0.2%
Operating Income	$523M	$298M	+75.7%
Net Income	$233M	-$196M	+218.6%

VTRS FY 2009 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena